Raksha Shah

Founder, CEO
Obsidio Therapeutics

Ms. Shah is currently the Founder, President & CEO of Obsidio Therapeutics, a late preclinical stage biotech company based in Irvine, CA. At Obsidio, Ms. Shah leads an innovative, seasoned team of drug development experts who are taking this groundbreaking technology from the lab to the clinic to provide sustainable benefits for patients with intractable cancers. Ms. Shah has 25+ years of leadership experience in life science and high tech both with large pharma companies like GlaxoSmithKline and Novartis and start-up companies. A seasoned entrepreneur, and results driven professional Ms. Shah has served as a Board Director, CFO, COO and CEO of multiple companies and her operational experience gives her the ability to integrate strategic vision with operational excellence to scale a company effectively. Ms. Shah thrives on the fast pace of the start-up environment and has spent the past thirteen years building companies from inception. Ms. Shah is proven at growing companies systematically, by building a top notch team, raising funding, by developing a go to market strategy to deliver on the mission, ensuring customer centric product development, generating revenues and repeatable performance to scale companies and deliver market share. Ms. Shah grew up in the United Kingdom and received her BSc. in Biology and her MBA in Finance & Marketing in the UK. Giving back to the community is a central part of Ms. Shah’s belief system and she strives to give back in a number of ways. Ms. Shah, serves as an Entrepreneur-in Residence (EiR) at UCI’s Applied Innovation Center and various incubators in southern California, where she mentors entrepreneurs with early stage companies. Ms. Shah also serves as an Ambassador for the Second Harvest Food Bank and volunteer for Working Wardrobes. You can follow Obsidio's progress on Ms. Shah's Twitter handle @rdsrocky www.obsidiotpx.com